Archive - July 2018
Alnylam’s amyloidosis drug heads latest crop of CHMP approvals
Historic New Drug Application for the use of Scenesse (afamelanotide) in Rare Metabolic Disorder Erythropoietic Protoporphyria (EPP)
Ocular Therapeutix Announces NDA Resubmission of Dextenza
Camurus Announces PDUFA Date for CAM2038 for the Treatment of Opioid Use Disorder
Karyopharm Initiates Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Selinexor as a Treatment for Patients with Penta-Refractory Multiple Myeloma
New compound turns back the clock on hair loss, skin damage
GSK shuts down 60-year-old facility in Bangladesh
Many Young People Unaware Of When Fertility Declines, Study Finds